ArticleClinical hypertension2018

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension.

Attila Juhasz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.